A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting
Clinical trial NCT06488170 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06488170
- Sponsor
- Almirall, S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-04
- Primary completion
- 2026-01-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.